| Pharmacogenomic information from CPIC and DPWG guidelines and its application on drug labels DY Yoon, S Lee, MS Ban, IJ Jang, SH Lee Translational and Clinical Pharmacology 28 (4), 189, 2020 | 21 | 2020 |
| A pharmacokinetic drug-drug interaction study between pregabalin and tramadol in healthy volunteers S Lee, Y Kim, JJS Lee, G Im, JY Cho, JY Chung, S Yoon European Journal of Clinical Pharmacology 74, 1605-1613, 2018 | 14 | 2018 |
| Pharmacokinetics of ursodeoxycholic acid in elderly volunteers compared with younger adults in a Korean population S Lee, S Yoon, H Chung, SC Ji, SH Yoon, KS Yu, JY Cho, JY Chung The Journal of Clinical Pharmacology 59 (8), 1085-1092, 2019 | 9 | 2019 |
| The utility of CYP3A activity endogenous markers for evaluating drug-drug interaction between sildenafil and CYP3A inhibitors in healthy subjects S Lee, AHJ Kim, S Yoon, J Lee, Y Lee, SC Ji, SH Yoon, SH Lee, KS Yu, ... Drug Metabolism and Pharmacokinetics 36, 100368, 2021 | 8 | 2021 |
| Urinary metabolic markers reflect on hepatic, not intestinal, CYP3A activity in healthy subjects S Lee, Y Lee, AHJ Kim, S Yoon, J Lee, SC Ji, SH Yoon, SH Lee, KS Yu, ... Drug Metabolism and Pharmacokinetics 36, 100374, 2021 | 7 | 2021 |
| Evaluation of the effects of food on levodropropizine controlled-release tablet and its pharmacokinetic profile in comparison to that of immediate-release tablet S Lee, KY Nam, J Oh, SH Lee, SM Cho, YW Choi, JY Cho, BJ Lee, ... Drug Design, Development and Therapy, 1413-1420, 2018 | 6 | 2018 |
| Current bioequivalence study designs in South Korea: a comprehensive analysis of bioequivalence study reports between 2013 and 2019 KY Huh, E Kim, S Lee, H Yoo, S Yoon, KS Yu, JY Chung Frontiers in Pharmacology 12, 651790, 2021 | 5 | 2021 |
| Physiologically based pharmacokinetic modeling of fimasartan, amlodipine, and hydrochlorothiazide for the investigation of drug–drug interaction potentials S Rhee, HA Lee, S Lee, E Kim, I Jeon, IS Song, KS Yu Pharmaceutical Research 35, 1-10, 2018 | 4 | 2018 |
| Population Pharmacokinetic Model of AST-001, L-Isomer of Serine, Combining Endogenous Production and Exogenous Administration in Healthy Subjects S Lee, SK Hwang, HS Nam, JS Cho, JY Chung Frontiers in Pharmacology 13, 891227, 2022 | 1 | 2022 |
| Pharmacokinetic and pharmacodynamic characteristics of tripegfilgrastim, a Pegylated G‐CSF, in pediatric patients with solid tumors S Lee, KT Hong, SJ Moon, JY Choi, CR Hong, HY Shin, JY Cho, IJ Jang, ... Clinical Pharmacology & Therapeutics 111 (1), 293-301, 2022 | 1 | 2022 |
| Pharmacokinetic comparison between a fixed-dose combination of fimasartan/amlodipine/hydrochlorothiazide 60/10/25 mg and a corresponding loose combination of fimasartan … J Jung, S Lee, J Oh, SH Lee, IJ Jang, D Lee, KS Yu Translational and Clinical Pharmacology 29 (1), 53, 2021 | 1 | 2021 |
| Pharmacokinetic comparison between fixed-dose combination of fimasartan/amlodipine 60/10 mg and the corresponding loose combination through partial replicated crossover study … E Yang, S Lee, H Lee, I Hwang, IJ Jang, KS Yu, SH Lee Translational and Clinical Pharmacology 27 (4), 134, 2019 | 1 | 2019 |
| The pharmacokinetic, safety, and tolerability profiles of eslicarbazepine acetate are comparable between Korean and White subjects S Hwang, S Lee, E Kim, I Hwang, JY Cho, JY Chung, IJ Jang, J Oh Clinical and Translational Science 15 (9), 2116-2126, 2022 | | 2022 |
